Reduction of CD8 T Cell Functionality but Not Inhibitory Capacity by Integrase Inhibitors.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
09 03 2022
Historique:
pubmed: 13 1 2022
medline: 29 4 2022
entrez: 12 1 2022
Statut: ppublish

Résumé

Although HIV-specific CD8 T cells are effective in controlling HIV infection, they fail to clear infection even in the presence of antiretroviral therapy (ART) and cure strategies such as "shock-and-kill." Little is known how ART is contributing to HIV-specific CD8 T cell function and the ability to clear HIV infection. Therefore, we first assessed the cytokine polyfunctionality and proliferation of CD8 T cells from ART-treated HIV+ individuals directly

Identifiants

pubmed: 35019724
doi: 10.1128/JVI.01730-21
pmc: PMC8906395
doi:

Substances chimiques

Anti-HIV Agents 0
HIV Integrase Inhibitors 0
Reverse Transcriptase Inhibitors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0173021

Références

Cell Rep. 2017 Dec 19;21(12):3458-3470
pubmed: 29262326
J Virus Erad. 2019 Jan 1;5(1):3-9
pubmed: 30800420
J Virol. 2005 Nov;79(21):13239-49
pubmed: 16227247
Medicine (Baltimore). 2016 Jul;95(30):e4429
pubmed: 27472741
J Int AIDS Soc. 2017 May 19;20(1):21171
pubmed: 28537062
PLoS Med. 2008 May 6;5(5):e100
pubmed: 18462013
Blood. 2011 Aug 25;118(8):2138-49
pubmed: 21734237
J Immunol. 2018 Dec 15;201(12):3546-3557
pubmed: 30446567
J Virol. 2007 Jul;81(14):7725-31
pubmed: 17494064
AIDS. 2010 May 15;24(8):1095-105
pubmed: 20400885
Cold Spring Harb Perspect Med. 2012 Apr;2(4):a007161
pubmed: 22474613
EBioMedicine. 2016 Jun;8:217-229
pubmed: 27428432
J Virol. 2003 Feb;77(3):2081-92
pubmed: 12525643
Curr Treat Options Infect Dis. 2019;11(4):372-387
pubmed: 33380904
J Virol. 2015 Oct;89(20):10176-89
pubmed: 26223643
Front Immunol. 2015 Oct 02;6:504
pubmed: 26483794
Obesity (Silver Spring). 2011 May;19(5):917-24
pubmed: 20885388
Immunology. 2011 Jun;133(2):190-6
pubmed: 21517838
Pathog Immun. 2016 Spring;1(1):68-106
pubmed: 27430032
Front Immunol. 2019 May 28;10:1168
pubmed: 31191539
Viral Immunol. 2017 Jan/Feb;30(1):3-12
pubmed: 27805477
J Virol. 2007 Nov;81(21):11749-57
pubmed: 17804505
PLoS Pathog. 2014 Nov 13;10(10):e1004473
pubmed: 25393648
Front Immunol. 2018 Jan 25;9:20
pubmed: 29422894
J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):213-21
pubmed: 21079516
Nat Med. 2017 Nov;23(11):1271-1276
pubmed: 28967921
Antimicrob Agents Chemother. 2018 May 25;62(6):
pubmed: 29661866
Pharmacol Res. 2019 Jan;139:524-534
pubmed: 30366100
Int J Infect Dis. 2021 Sep;110:21-28
pubmed: 34273516
PLoS Pathog. 2018 Apr 13;14(4):e1006973
pubmed: 29652923
J Acquir Immune Defic Syndr. 2017 Dec 15;76(5):527-531
pubmed: 28825943
J Clin Invest. 2017 Aug 1;127(8):3126-3135
pubmed: 28714868
J Clin Invest. 2018 Feb 1;128(2):876-889
pubmed: 29355843
J Virol. 2014 Nov;88(21):12793-801
pubmed: 25165102
Am J Physiol Endocrinol Metab. 2010 Jan;298(1):E49-58
pubmed: 19887598
BMC Cancer. 2020 Jul 13;20(1):650
pubmed: 32660441
J Clin Invest. 2016 Feb;126(2):455-63
pubmed: 26731469
Curr Opin HIV AIDS. 2016 Sep;11(5):492-500
pubmed: 27254748
Blood. 2006 Jun 15;107(12):4781-9
pubmed: 16467198
Curr Opin Endocrinol Diabetes Obes. 2010 Oct;17(5):446-52
pubmed: 20585248
Methods Enzymol. 2014;542:125-49
pubmed: 24862264
Front Immunol. 2019 Feb 26;10:291
pubmed: 30863403
J Virol. 2020 Sep 15;94(19):
pubmed: 32669328
Front Immunol. 2018 Jun 22;9:1452
pubmed: 29988382
Sci Rep. 2017 Aug 10;7(1):7785
pubmed: 28798348
Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):5914-5919
pubmed: 30850527
Curr Opin Immunol. 2010 Jun;22(3):314-20
pubmed: 20189791
Mol Metab. 2015 Jul 15;4(9):631-42
pubmed: 26413469
J Virol. 2020 Apr 16;94(9):
pubmed: 32051267
Nat Immunol. 2015 Jun;16(6):584-9
pubmed: 25990814
Nat Med. 2015 Feb;21(2):132-9
pubmed: 25599132
Cell Host Microbe. 2018 Jan 10;23(1):14-26
pubmed: 29324227
Curr Opin HIV AIDS. 2016 Jul;11(4):409-16
pubmed: 27054280
JCI Insight. 2019 Jun 20;4(12):
pubmed: 31217351

Auteurs

Enrico Richter (E)

Institute of Virology, University Hospital, University of Bonngrid.10388.32, Bonn, Germany.
German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany.

Lea Bornemann (L)

Institute for Experimental Immunology and Imaging, University Duisburg-Essen, Essen, Germany.

Marek Korencak (M)

Institute of Virology, University Hospital, University of Bonngrid.10388.32, Bonn, Germany.
German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany.

Galit Alter (G)

Massachusetts General Hospitalgrid.32224.35, Boston, Massachusetts, USA.

Marc Schuster (M)

Institute for Experimental Immunology and Imaging, University Duisburg-Essen, Essen, Germany.

Stefan Esser (S)

HPSTD HIV Clinic, University Hospital, University Duisburg-Essen, Essen, Germany.
Institute for Translational HIV Research, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

Christoph Boesecke (C)

Department of Medicine I, University Hospital Bonn, University of Bonngrid.10388.32, Bonn, Germany.

Juergen Rockstroh (J)

Department of Medicine I, University Hospital Bonn, University of Bonngrid.10388.32, Bonn, Germany.

Matthias Gunzer (M)

Institute for Experimental Immunology and Imaging, University Duisburg-Essen, Essen, Germany.
Leibniz-Institut für Analytische Wissenschaften-ISAS-e.V., Dortmund, Germany.

Hendrik Streeck (H)

Institute of Virology, University Hospital, University of Bonngrid.10388.32, Bonn, Germany.
German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH